Sign in

CIK 0001400118

  • Emerging growth company

Sagimet Biosciences Inc.

Sign in to watch
Ticker
SGMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205991472
Phone
+1 650-561-8600
Business address
950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
Former names
3-V Biosciences, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-14 Kemble George Director Option exercise 10b5-1 +326,618 $6.36 $2.1M 388,779
2026-08-14 Kemble George Director Option exercise 10b5-1 +24,369 $6.36 $155K 413,148
2026-08-14 Kemble George Director Sale 10b5-1 −350,987 $10.23 $3.6M 62,161
2026-08-14 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −326,618 31,455
2026-08-14 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −24,369 11,608
2026-08-11 Kemble George Director Option exercise 10b5-1 +9,751 $6.36 $62K 71,912
2026-08-11 Kemble George Director Option exercise 10b5-1 +10,455 $6.36 $66K 82,367
2026-08-11 Kemble George Director Sale 10b5-1 −20,206 $9.95 $201K 62,161
2026-08-11 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −9,751 358,073
2026-08-11 Kemble George Director Option exercise · Stock Option (Right to Buy) 10b5-1 −10,455 35,977
2026-07-20 Happel David President & CEO Sale −64,051 $7.76 $497K 741,570
2026-07-20 Rozek Elizabeth Chief Legal & Admin. Officer Sale −10,545 $7.76 $82K 224,414
2026-07-20 Kemble George Director Sale 10b5-1 −18,844 $7.46 $141K 62,161
2026-06-12 SEIDENBERG BETH C Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Hoelscher Paul W. Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Jarrett Jennifer Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 GRAMMER ELIZABETH A Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Kemble George Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-06-12 Phillips Anne M. Director Grant or award · Stock Option (Right to Buy) +39,567 39,567
2026-05-28 Chauche Thierry Chief Financial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000

Page 1 of 10 · 194 trades